- Research works
- 21 ▲ 303% vs 2013–17
- Citations
- 411 19.5 per fractional work
- Top-10% rate
- 23.2% record average 16.5%
- Open access
- 82% world 28%
Not ranked overall: Nouscom (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Nouscom (Italy)?
Ranked on the composite score, Elisa Scarselli lead among researchers whose main affiliation is Nouscom (Italy).
- 1 Elisa Scarselli Italy · #1,429,184 worldwide 13 citations · 19 works
Which keywords describe research at Nouscom (Italy)?
By fractional works in all years, weighted toward what it does more of than the world: Antigen Presentation, Cancer Immunotherapy, Gene Therapy, Innate Immunity, Immunity, AAV, Viral Vectors and Dendritic Cells.
- Herpesviruses
- Tumor Regression
- Immune Response
- Glycosylation
- PD-1 and PD-L1
- Tumor Microenvironment
- Epidemiology
- Dendritic Cells
- AAV
- Innate Immunity
- Cancer Immunotherapy
- Antigen Presentation
- Gene Therapy
- Immunity
- Viral Vectors
- Tumor Antigen
- Immunotherapy
- Immune Checkpoint Blockade
- Vaccine
- Epitope Prediction
- Peptide-MHC Binding
- Herpes Zoster
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 22 words, with their numbers
- Antigen Presentation4▲ 198×2 topics
- Cancer Immunotherapy4▲ 126×2 topics
- Gene Therapy3▲ 61×2 topics
- Innate Immunity3▲ 44×2 topics
- Immunity3▲ 43×2 topics
- AAV3▲ 217×1 topic
- Viral Vectors3▲ 217×1 topic
- Dendritic Cells3▲ 116×1 topic
- Tumor Antigen3▲ 165×1 topic
- Epidemiology3▲ 3.2×9 topics
- Immunotherapy2▲ 16×5 topics
- Tumor Microenvironment2▲ 24×2 topics
- Immune Checkpoint Blockade2▲ 140×1 topic
- PD-1 and PD-L12▲ 140×1 topic
- Vaccine2▲ 20×4 topics
- Glycosylation2▲ 35×3 topics
- Epitope Prediction1▲ 339×1 topic
- Immune Response1▲ 11×5 topics
- Peptide-MHC Binding1▲ 339×1 topic
- Tumor Regression1▲ 73×2 topics
- Herpes Zoster1▲ 104×1 topic
- Herpesviruses1▲ 104×1 topic
Which research topics does Nouscom (Italy) publish most on?
By volume in 2022–2025: Immunotherapy and Immune Responses, Virus-based gene therapy research, vaccines and immunoinformatics approaches and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immunotherapy and Immune Responses Immunology 2 works
- 2 Virus-based gene therapy research Genetics 1 works
- 3 vaccines and immunoinformatics approaches Molecular Biology 1 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 5 Genetic factors in colorectal cancer Pathology and Forensic Medicine 1 works
- 6 Cutaneous Melanoma Detection and Management Oncology 1 works
- 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 8 Cancer Genomics and Diagnostics Cancer Research 0 works
- 9 CAR-T cell therapy research Oncology 0 works
- 10 Herpesvirus Infections and Treatments Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Nouscom (Italy)'s research output changed?
Output in 2018–2022 was 303% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rome
- Sapienza University of Rome
- University of Rome Tor Vergata
- Istituti di Ricovero e Cura a Carattere Scientifico
- National Research Council
- Roma Tre University
- Istituto Superiore di Sanità
- National Agency for New Technologies, Energy and Sustainable Economic Development
- Agostino Gemelli University Polyclinic
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.